Robert Stevens

Chief Tech/Sci/R&D Officer at CorneaGen, Inc.

Health Technology

Consumer Services

Profile

Robert J.
Stevens is currently a Senior Vice President-Research & Development at CorneaGen, Inc. He previously worked as a Director at Acucela, Inc. Stevens received his undergraduate and graduate degrees from the University of Washington.

Robert Stevens active positions

Companies	Position	Start
CorneaGen, Inc. CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA.	Chief Tech/Sci/R&D Officer	-

All active positions of Robert Stevens

Former positions of Robert Stevens

Companies	Position	End
ACUCELA INC	Director/Board Member	-

See the detail of Robert Stevens's experience

Training of Robert Stevens

University of Washington

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Stevens's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Acucela, Inc. Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA.	Health Technology
CorneaGen, Inc. CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA.	Health Technology